title: Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology.
abstract: OBJECTIVE
  We sought to estimate the rates and types of evaluation in women with atypical glandular cells of undetermined significance (AGC-US) on cervical cytology and to assess these findings on the basis of published management guidelines.
  
  
  METHODS
  The rates of histologic sampling, comprehensive initial evaluations, and secondary evaluations were assessed in 477 women with an AGC-US Pap test from 1998 to 2001. A comprehensive evaluation was defined as a colposcopy and an endocervical curettage with or without a cervical biopsy. For women aged 35 or older, a comprehensive evaluation also included an endometrial biopsy. A secondary evaluation consisted of a diagnostic cone biopsy.
  
  
  RESULTS
  Sixty-four percent of women with an AGC-US Pap test had histologic sampling; 36% were followed by repeat Pap test only. Thirty-six percent of women with an AGC-US Pap test had a comprehensive evaluation. Women with an AGC-US Pap test that was subclassified as malignant-appearing had higher rates of histologic and comprehensive evaluations than women with a benign-appearing or unspecified AGC-US Pap test (P < .01). Twenty-eight percent of women aged 35 or older had comprehensive evaluations compared with 57% of women younger than the age of 35 (P < .01). Secondary evaluations were performed in 8% of women with persistent AGC-US Pap tests and 2% of women with malignant-appearing AGC-US Pap tests after negative initial histologic evaluations. Twelve of the 42 cases of disease (29%) were diagnosed more than 1 year from the initial AGC-US Pap test.
  
  
  CONCLUSIONS
  On the basis of accepted management guidelines, these data suggest that women with AGC-US Pap tests are undermanaged in both their initial and secondary evaluations.
authors.affiliation: Hartford Hospital, Hartford, Connecticut 06102, USA.
authors.forename: Kathryn E
authors.initials: KE
authors.lastname: Sharpless
authors.forename: Peter F
authors.initials: PF
authors.lastname: Schnatz
authors.forename: Srinivas
authors.initials: S
authors.lastname: Mandavilli
authors.forename: John F
authors.initials: JF
authors.lastname: Greene
authors.forename: Joel I
authors.initials: JI
authors.lastname: Sorosky
mesh_terms: D000328:Adult; D001707:Biopsy, Needle; D002584:Cervix Uteri / Q000473:pathology; D003127:Colposcopy; D019092:Conization; D004107:Dilatation and Curettage; D004717:Endometrium / Q000473:pathology; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D017410:Practice Guidelines as Topic; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis* / Q000628:therapy / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D014626:Vaginal Smears